718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models

标题
718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 9, Issue Suppl 2, Pages A747-A747
出版商
BMJ
发表日期
2021-11-09
DOI
10.1136/jitc-2021-sitc2021.718

向作者/读者发起求助以获取更多资源

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now